ViiV's licensing talks with Medicines Patent Pool progressing towards a deal

 
• By Anju Ghangurde

ViiV Healthcare, the specialist HIV joint venture formed by GlaxoSmithKline (which owns 85%) and Pfizer (15%) in late 2009, and the Medicines Patent Pool appear to have made considerable progress in their negotiations towards a potential licensing pact for ViiV's products.

More from Anti-infective

More from Therapeutic Category